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To investigate the impact of the inhibitor of growth family 4 (ING4) on growth of glioma cells (U251 cells) 
and its potential molecular mechanism, total RNA was extracted from the embryonic tissues and ING4 
was amplified by RT-PCR and cloned into pEGFP-C2 vector. U251 cells were transfected with eukaryotic 
expression vector pEGFP-ING4 mediated by cationic polymers polyethylenimine (PEI). Flow cytometry 
and G418 were used to screen the cells successfully transfected with pEGFP-ING4. PEGFP-ING4 group, 
pEGFP group and blank control group (without transfection) were included in this study. Morphological 
examination, MTT assay and Hochest staining were employed to detect the proliferation and apoptosis of 
U251 cells. RT-PCR, immunohistochemitry and western blot were recruited to determine the mRNA and 
protein expression of ING4, respectively. ELISA was performed to measure the VEGF level in the 
supernatant of U251 cells. Sequencing of pEGFP-ING4 showed sequence correctness and the tranfection 
efficiency was 84% for pEGFP-ING4 and 82% for pEGFP. Results from RT-PCR, immunohistochemistry 
and western blot revealed significantly increased ING4 expression. When compared with the pEGFP 
group and blank group, the growth inhibition rate and apoptotic rate 72 h after transfection in the pEGFP-
ING4 group were significantly higher (P < 0.05), but the VEGF content was not significantly changed (P > 
0.05). ING4 can be highly expressed in the pEGFP-ING4 group and remarkably suppress the growth of 
U251 cells through inducing apoptosis but not suppressing VEGF expression.  
 





Glioma, the most common intracranial malignant tumor, is 
often associated with poor prognosis. At present, it has 
been evidenced that the occurrence of glioma is a 
polygenic and multi-step process. Not only the activation 
of proto-oncogenes but the inactivation of tumor suppressor 
genes is involved in the occurrence and development of 
glioma. Recent studies have shown that the inhibitor of 
growth family member 4 (ING4) plays an important role in 
the suppression of tumor growth, promotion of tumor cell 
apoptosis, presence of contact inhibition between cells, 
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enhanced sensitivity of cancer cells to cytotoxic agents 
(Kim et al., 2004; Zhang et al., 2004; Li et al., 2008, 
2009). We speculate that ING4 may play an important 
role in the pathogenesis of glioma. In the present study, 
the effect of ING4 on glioma cells (U251 cells) and its 
potential mechanism were investigated, which may provide 




MATERIALS AND METHODS 
 
Plasmid, bacterial strain and cell line 
 
pEGFP-C2 (invitrogen, USA), pEGFP-ING4, DH5α Escherichia coli 
and U251 cell line (from the Department Of Neurosurgery, Sun Yat- 
Sen    Memorial    Hospital,   Sun   Yat-Sen   University,  Zhongshan 









Trizol reagent (Invitrogen, USA), RT-PCR kit (Nanjing Keygentec, 
China), primers for ING4 (Invitrogen, USA), GoTaq DNA 
polymerase (Promega, USA), pGEM-T vector systems (Promega, 
USA), T4 DNA ligase (TaKaRa, Japan), ampicillin, kanamycin 
(Sigma, USA), G418 (Merck, USA), plasmid DNA extraction mini kit 
(Qiagen, Germany), EcoRI and SalI restriction endonucleases 
(TaKaRa, Japan), DNA gel extraction kit (Qiagen, Germany), DMEM 
high glucose (GIBICO, USA), trypsin  (Invitrogen, USA), poly-
ethylen-imine (PEI; China), rabbit anti-human ING4 antibody (PTG, 
USA), goat anti-rabbit IgG (Boster, China) and SABC immune-





PCR instrument (Bio-Rad, USA), gel imager (UVIDOC, UK), gel 
imaging system (Cole Parmer, USA), Universal 32 R refrigerated 
centrifuge (HetticH, Germany), UV-1206 ultraviolet spectro-
photometer (Shimadzu, Japan), clean bench (Airtech, Japan), 
inverted microscope (Leica, Germany), constant temperature and 
humidity incubator (Forma scientific, USA) and converted 
fluorescence microscope (Nikon, Japan) were used in this sutdy 
 
 
Cell culture and immunohistochemitry 
 
When cell confluence reached nearly 100%, U251 cells were fixed 
in 4% paraformaldehyde for 90 min and then, the endogenous 
peroxidase in these cells was inactivated by treatment with 
hydrogen peroxide in methanol solution at room temperature. 
These cells were blocked with 5% BSA and then, treated with rabbit 
anti-human GFAP antibody (1:200) at room temperature for 2 h 
followed by washing three times (2 min per time). Subsequently, the 
cells were incubated with biotin conjugated secondary antibody for 
20 min at room temperature followed by washing three times (2 min 
per time). Then, the cells were treated with the streptavidin-biotin-
peroxidase complex for 20 min at room temperature followed by 
washing four times (5 min per time). Color development was 
performed with DAB at room temperature for 10 min. After washing 
with ddH2O, cells were counterstained with hematoxylin.  
 
 
Construction and confirmation of pEGFP-ING4 
 
Total RNA was extracted from the human placenta and reversely 
transcribed into cDNA which then served as templates for ampl-
ification by PCR. The target fragment was connected to the T 
vectors by TA cloning followed by transformation, amplification and 
plasmid retrieval. Positive colonies were identified after restriction 
enzyme digestion. After digestion with both restriction enzymes, the 
positive plasmid and vector pEGFP were retrieved by gel excision 
after electrophoresis. Then, the target fragment was connected to 
the vector pEGFP followed by transformation, amplification and 
plasmid retrieval. Finally, enzyme digestion and sequencing were 
conducted to confirm the positive colonies. 
 
 
Cell transfection and screening of positive colonies 
 
U251 cells were transfected with pEGFP-ING4 (positive control) or 
pEGFP (negative control) and those without transfection served as 
blank controls. Forty eight hours after transfection, the expression 





fluorescence microscope. After G418 (800 µg/ml) screening for 14 
days,flow cytometry was performed to measure the GFP expression 
aiming to detect the transfection efficiency. Then, RT-PCR, western-
blot and immunohistochemistry were employed to determine the 
mRNA and protein expression of ING4, respectively. 
 
 
Detection of cell proliferation by MTT assay 
 
After digestion with trypsin, U251 cells were harvested and single 
suspension was prepared with the medium containing 10% 
newborn calf serum. These cells were seeded into a 96-well plate at 
a density of 1×104 (200 µl/well) and the experiment was conducted 
in triplicates. After 1, 3 or 5 days of culture, 20 µl of MTT solution 
(final concentration: 5 mg/ml) were added to each well followed by 
incubation for 4 h. Then, the supernatant was removed and 150 µl 
of DMSO were added to each well followed by shaking until the 
crystals resolved. The absorbance (A) of each well was determined 
at 492 nm with a microplate reader. The A was recorded as means 
± standard deviation (SD).  
 
 
Detection of apoptosis by Hochest staining 
 
After digestion with trypsin, cells were harvested, resuspended and 
seeded at a density of 1×105 followed by incubation for 3 days. 
Then, the medium was removed and cells were fixed in 0.5 ml of 
fixative solution for 10 min. The fixative solution was removed and 
cells were rinsed with PBS two times (3 min per time). 
Subsequently, these cells were stained with 0.5 ml of Hoechst 
solution for 5 min followed by rinsed with PBS two times (3 min per 
time). These cells were observed under a fluorescence microscope 
and positive cells had blue nuclei. Viable cells have large nuclei and 
the fluorescence is evenly diffuse. Apoptotic cells have shrunk 
nuclei or karyorrhexis or pyknosis. Five fields at high magnification 
were selected randomly from each group and the number of cells 
(viable or apoptotic) and that of cells having karyorrhexis or 
pyknosis were detected. The apoptosis rate was calculated as 
follow and expressed as means ± SD: apoptosis rate = number of 
apoptotic cells/total number of cells.  
 
 
Detection of VEGF content by ELISA 
 
After screening with G418 (800 µg/ml) for 14 days, the supernatant 
was collected and the VEGF content was determined by ELISA. 




Statistical analysis  
 
Statistical analysis was performed with SPSS version 13.0 
statistical software and comparisons were done with one way 






Identification of U251 cells 
 
The morphological features of U251 cells were consistent 
with those of glioma cells (Figure 1a,b). GFAP staining 
showed brown granules in the cytoplasm of U251 cells, 
suggesting glioma cells (Figure 1c,d).  






Figure 1. Morphological features of U251 cells: A, viable U251 cells (×100); B, viable U251 
cells (×200); C, GFAP immunohistochemistry: brown granules in the cytoplasm (×100); D, 






Figure 2. Electrophoresis after digestion with both restriction 
enzymes. Lane 2: Marker (1 kb): from top to bottom 10000, 8000, 
6000, 5000, 4000, 3000, 2500, 2000, 1500, 1000, 750, 500 and 250 
bp. The brightest bands in the lane 2 were at 3000 and 1000 bp, 
respectively. Lane 1: products after digestion with both restriction 
enzymes. A band at about 10000 bp represented pEGFP plasmid 




Construction and identification of pEGFP-ING4 
eukaryotic expression vector 
 
The  reverse  transcribed  cDNA  was  used  for  PCR  for 
amplification. The target fragments were then connected 
to T vectors with a TA cloning technique, followed by 
transduction, amplification and plasmid extraction. The 
positive colonies were screened by enzyme digestion. 
The recombinant plasmid pEGFP-ING4 was digested with 
two enzymes and then subjected to agarose gel electro-
phoresis. Results showed two bands; one band was 
about 10000 bp which was similar to the length of pEGFP 
plasmid and the other band (about 1000 bp) was similar 
to the ORF of ING4 in the length (Figure 2). 
 
 
Screening of positive colonies by G418 and flow 
cytometry 
 
Plasmids pEGFP and pEGFP-ING4 were used to trans-
fect U251 cells which were then, screened by G418 (800 
µg/ml). GFP positive cells could be identified. Sub-
sequently, flow cytometry was performed to acquire GFP 
positive colonies. Results showed that the proportion of 
GFP positive U251 cells was greater than 90% (Figure 3). 
 
 
ING4 expression in U251 cells 
 
Immunohistochemistry was performed for ING4. Positive 
staining was observed in cells after pEGFP-ING4. The 
nucleus was stained dark and apoptotic body was 
evident. However, there was no positive staining in the 
pEGFP group and blank control group (Figure 4). 






Figure 3. Screening of positive colonies by G418 and flow cytometry. A, Cells in the pEGFP group 
under a fluorescence microscope after screening; B, merged photograph of cells in the pEGFP 
group. The proportion of GFP positive cells was greater than 90% and the cell confluence reached 
nearly 100% (×200). C, cells in the pEGFP-ING4 group under fluorescence microscope after 
screening; D, merged photograph of cells in the pEGFP-ING4 group. The proportion of GFP 
positive cells was greater than 90% and the cell confluence was obviously lower than that in the 






Figure 4. Detection of ING4 expression in the U251 cells by immunohistochemistry. A, 
Immunohistochemistry for ING4 in the pEGFP-ING4 group. Brown granules were 
observed in the cytoplasm, the nuclei were dark and the amount of cells was small 
(×100); B, Immunohistochemistry for ING4 in the pEGFP-ING4 group. Brown granules 
were observed in the cytoplasm, and apoptotic body was present in the cells (×400); C, 
Immunohistochemistry for ING4 in the blank controls. No brown granules were noted in 
the cytoplasm (×100); D, Immunohistochemistry for ING4 in the pEGFP group. There 
were not brown granules in the cytoplasm (×100).  






Figure 5. U251 cells after transfection. A, One day after transfection, the amount of cells was still small (×200); B, three days 
after transfection, the cell confluence reached nearly 100%; C, seven days after transfection, formation of overlapping cell 






Figure 6. U251 cells in the pEGFP group under fluorescence microscope. A, U251 cells under a 
fluorescence microscope one day after transfection; B, U251 cells in the same field under a light 
microscope one day after transfection (×100); C, merged photograph of U251 cells one day after 
transfection (×100) and the amount of cells was small; D, U251 cells under a fluorescence microscope 
three days after transfection; E, U251 cells in the same field under a light microscope three days after 
transfection (×100); F, merged photograph of U251 cells three days after transfection (×100) and the 
cell confluence reached nearly 100%; G, U251 cells under a fluorescence microscope seven days after 
transfection; H, U251 cells in the same field under a light microscope seven days after transfection 
(×100); I, merged photograph of U251 cells seven days after transfection (×100) and overlapping cell 




Morphological characteristics of U251 cells after 
transfection with pEGFP-ING4 
 
It was reported that ING4 could change the cell 
morphology and disable the contact inhibition of cells. 
Fluorescence microscopy was conducted to observed 
cells in the blank control group (Figure 5), pEGFP group 
(Figure 6) and pEGFP-ING4 group (Figure 7) at days 1, 3 
and 7. Results showed cell confluence did not reach 
100% at day 1 and GFP expressing cells were observed 
in pEGFP-ING4 group and pEGFP group. Three days 
after transfection, the cell confluence reached nearly 
100% in blank control group and pEGFP group, but not in 
the pEGFP-ING4 group. Fluorescence microscopy 
showed GFP expressing cells in pEGFP-ING4 group and 
pEGFP  group.  Seven  days  after  transfection,   the  cell  






Figure 7. U251 cells in the pEGFP-ING4 group under a fluorescence microscope. A, U251 cells under a 
fluorescence microscope one day after transfection; B, U251 cells in the same field under a light microscope 
one day after transfection (×100); C, merged photograph of U251 cells one day after transfection (×100) and 
the amount of cells was little; D, U251 cells under a fluorescence microscope three days after transfection; E, 
U251 cells in the same field under a light microscope three days after transfection (×100); F, merged 
photograph of U251 cells three days after transfection (×100) and the amount of cells was still small; G, U251 
cells under a fluorescence microscope seven days after transfection; H, U251 cells in the same field under a 
light microscope seven days after transfection (×100); I, merged photograph of U251 cells seven days after 




confluence reached 100% and overlapping growth was 
also noted in blank control group and pEGFP group, 
which were not observed in pEGFP-ING4. GFP expres-
sing cells in pEGFP-ING4 group and pEGFP group were 
still found. These findings further demonstrated the 




Effect of pEGFP-ING4 transfection on the growth of 
U251 cells  
 
One, three and five days after transfection, the A in the 
pEGFP-ING4  group had  a  decreased tendency (Figure 8). 
The A in the pEGFP-ING4 group was 0.2607 ± 0.0464% 
at day 3 and 0.1920 ± 0.0105% at day 5, which were 
significantly higher than those in the pEGFP group and 
blank control group (P < 0.05). There was no marked 
difference between pEGFP group and blank control group 
(P > 0.05). 
 
 
Effect of pEGFP-ING4 transfection on the apoptosis 
of U251 cells 
 
Hochest staining revealed apoptotic characteristics 
including pyknosis and karyorrhexis in 3 groups 3 days 
after  transfection,  which  however, were more obvious in  






Figure 8. Growth curve of U251 cells. One, three and five days after transfection, the 
cell proliferation decreased in the pEGFP-ING4 group but had an increased tendency in 
the pEGFP group and the blank control group. the A in the pEGFP-ING4 group 3 and 5 
days after transfection were significantly higher than those in the pEGFP group and 
blank control group (P < 0.05). There was no marked difference between pEGFP group 






Figure 9. Hochest staining. A, Three days after transfection, cells in the pEGFP-ING4 group were 
observed under a fluorescence microscope and a lot of apoptotic cells were observed (×100); B, 
Merged photograph from the same field in the pEGFP-ING4 group (×100); C, Three days after 
transfection, cells in the pEGFP group were observed under a fluorescence microscope and a small 
amount of apoptotic cells were observed (×100); D, Merged photograph from the same field in the 
pEGFP group (×100); E, Three days after transfection, cells in the blank control group were observed 
under a fluorescence microscope and a small amount of apoptotic cells were observed (×100); F, 




pEGFP-ING4 than in blank control group and pEGFP 
group (Figure 9). The apoptosis rate was 29.0 ± 1.2% in 
pEGFP-ING4   group    and   markedly   higher   than  the 
remaining two groups (P < 0.05). There was no 
significant difference between blank control group and 
pEGFP group in the apoptosis rate (P > 0.05) (Figure 10). 






Figure 10. Apoptosis rate of U251 cells. The apoptosis rate in the pEGFP-ING4 group was 
significantly higher than that in the blank control group and the pEGFP group (P < 0.05). There was no 
marked difference in the poptosis rate between the blank control group and the pEGFP group (P > 






Figure 11. The mean VEGF content was 2.239 ng/ml in the pEGFP-ING4 group, 2.279 ng/ml 




Effect of pEGFP-ING4 transfection on the VEGF 
expression 
 
After screening with G418 (800 µg/ml) for 14 days, ELISA 
was performed to detect the VEGF content in the 
supernatant. Statistical analysis showed there was no 
significant difference in the VEGF content between three 
groups (P > 0.05). This result suggested that pEGFP-ING4 
transfection did not suppress the VEGF expression 





In 1996, Garkavlsev et al. identified the inhibitor of growth 
family member 1 (ING1) in the normal mammary epithelial 
cells and breast cancer cells through subtractive 
hybridization (Garkavtsev et al., 2004). Later, the other 
members of the inhibitor of growth family were found and 
they have been shown to play an important role in the 
suppression of cancer growth. Therefore, the inhibitor of 
growth family has been a hot topic in the recent research. 
ING4 is a recently found tumor suppressor gene and 
evidence revealed ING4 that it is involved in the patho-
genesis of cancers, acclimatization to hypoxia and other 
processes (Garkavtsev et al., 2004; Zhang et al., 2010; 
Xie et al., 2009; Zhao et al., 2010; Ozer and Bruick, 2005). 
Studies have demonstrated that ING4 could suppress the 
cell growth and apoptosis in liver cancer cells (HepG2), 





(RKO) (Xie et al., 2009; Zhang et al., 2004; Shen et al., 
2007).   
Garkavlsev et al. investigated the relationship between 
ING4 and glioma. Garkavlsev et al. (2004) demonstrated 
that the ING4 expression was negatively associated with 
the severity of glioma by PCR and ING4 could markedly 
inhibit the growth of U87 cells (Chen and Deng, 2008). In 
China, Zhao et al. (2007) also indicated that adenovirus 
mediated ING4 gene transfection could suppress the 
proliferation of glioma cells (C6 cells) and induce apoptosis. 
In the present study, after ING4 transfection, the morpho-
logy of U251 cells was observed and the proliferation and 
apoptosis were detected through MTT assay and Hochest 
staining, respectively. These results also revealed that the 
growth of U251 cells was dramatically suppressed 
accompanied by evident apoptosis induction.  
There was evidence that ING4 could suppress the 
angiogenesis. Suppressed angiogenesis was observed in 
the human glioma cells (U87 cells) after ING4 treatment 
which may be related to the suppressed VEGF activity or 
other pathways (Chen and Deng, 2008; Xie et al., 2008). 
In the present study, over expression of ING4 did not 
influence the VEGF expression in the U251 cells and the 
exact mechanism underlying the effect of ING4 on the 
angiogenesis should be further study (Xie et al., 2009).  
In the present study, the eukaryotic expression vector 
carrying ING4 gene was successfully constructed and 
transfected into glioma cells (U251 cells). The impacts of 
ING4 on the growth and apoptosis of U251 cells and on 
the VEGF expression were investigated, which may 
provide basis for the further studies on ING functions as 
well as the potential mechanism and also present 
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